Breast cancer
Results
Phase 3
This trial looked at whether the hormone therapy drug tamoxifen could reduce the risk of breast cancer developing in women who are at a high risk of getting it.
This trial was supported by Cancer Research UK.
Recruitment start: 14 April 1992
Recruitment end: 30 March 2001
Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.
Professor Jack Cuzick
Cancer Research UK
This is Cancer Research UK trial number CRUK/04/026.
Last reviewed: 12 Dec 2014
CRUK internal database number: 160
About Cancer generously supported by Dangoor Education since 2010. Learn more about Dangoor Education
What to ask your doctor about clinical trials.
Meet and chat to other cancer people affected by cancer.
Questions about cancer? Call freephone 0808 800 40 40 from 9 to 5 - Monday to Friday. Alternatively, you can email us.
